Home
Storia in 2 fonti
Prostate Cancer Drug Linked to Lower Risk of Cognitive Decline
Darolutamide offers 'an option for preserving cognitive health' in advanced disease, expert says
- ·
healio.com
‘Clearly different’: Cognitive effects vary by treatment in advanced prostate cancer
CHICAGO — The cognitive effects men with advanced prostate cancer experience during treatment may vary based on the therapy they receive, according to randomized phase 2 trial…
- ·
medpagetoday.com
Prostate Cancer Drug Linked to Lower Risk of Cognitive Decline
Darolutamide offers 'an option for preserving cognitive health' in advanced disease, expert says